Plasma levels of brain natriuretic peptide: a potential marker for HIV-related cardiomyopathy.
One of the most common and life-threatening cardiovascular complications of HIV-infection is severe global left ventricular dysfunction due to primary heart muscle disease. At present, there is no single, cost-effective and reliable method of identifying the highly prevalent HIV-related cardiac dysfunction. Nonetheless, growing evidence supports the hypothesis that brain natriuretic peptide measurement has the potential to detect patients who develop HIV-related cardiomyopathy. If true, this hypothesis would have important clinical and public health implications.
Carrillo-Jimenez
Rodolfo
R
Department of Cardiology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Lamas
Gervasio A
GA
Henneken
Charles H
CH
D000818:Animals; D015415:Biomarkers / Q000097:blood; D009202:Cardiomyopathies / Q000097:blood* / Q000209:etiology; D015658:HIV Infections / Q000097:blood* / Q000150:complications; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain